Ms. Holmes was convicted in January of four counts of defrauding investors in a yearslong scheme at the company that claimed to be able to do comprehensive tests with a tiny amount of blood. She faces up to 20 years in prison on each count at her Nov. 18 sentencing.
She requested a new trial in September, saying a witness had recanted his testimony. But that witness denied those claims.
U.S. District Judge Edward Davila ruled Nov. 7 that Ms. Holmes didn’t produce material new evidence or prove government misconduct and that a new trial was unlikely to lead to an acquittal, the Journal reported.
Her attorneys didn’t respond to a request from the news outlet for comment. The news was first reported Nov. 7 by Reuters.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
